Abstract:We previously demonstrated that β-lapachone (β-Lap) exerts stronger anticancer activity on oxaliplatin-resistant HCT116 colorectal cancer cells (Oxp-R-HCT 116 cells) than parental HCT116 cells (p-HCT 116 cells) by downregulating the oxaliplatin resistance-related upregulated proteins (Oxp-RR-Proteins) proteins in Oxp-R-HCT 116 cells, such as SOD1, MAPK, and nucelophosmin. We also demonstrated polyphenols extracted from Korean Artemisia annua L. (pKAL) exerts anticancer activity on radio-resistant MDA-MB-231 human breast cancer cells by suppressing stem cell phenotype, β-catenin, and MMP-9. In this study, we found that pKAL significantly enhanced the anticancer activity of β-lapachone (β-Lap) on oxaliplatin-resistant (Oxp-R) HCT116 colorectal cancer cells. The aim of this study is to elucidate how pKAL enhance the anticancer effects of β-Lap on Oxp-R-HCT 116 cells. CCK-8 assay, phase-contrast microscopy analysis, and morphological analysis with hematoxylin stain revealed that the anticancer effect of β-Lap is more enhanced by pKAL on Oxp-R-HCT 116 cells over 60 hr. This phenomenon was associated with suppression of oxaliplatin resistance-related upregulated proteins (Oxp-RR-Proteins) (p53, ERK, and β-catenin), and downregulation of cell survival- and stemness-related proteins (TERT, CD44 and EGFR) that were not up-regulated in Oxp-R-HCT 116 cells. Protein-protein interaction network analysis of the 21 proteins that showed large difference in expression between before and after the combined treatment of pKAL and β-Lap in HCT116-OxPt-R cells revealed that the enhanced anticancer effect of β-Lap by pKAL was related to the inhibition of negative regulation of apoptotic process and the induction of DNA damage through TERT, CD44, and EGFR-mediated multiple signaling networks. The detailed western blot analysis for anti-cancer effects of pKAL revealed that pKAL alone also suppressed the expression of TERT, CD44 and EGFR in p-HCT 116 cells as well as Oxp-R-HCT 116 cells while β-Lap alone did not influence the expression of them. In addition, for some of the Oxp-RR-Proteins of Oxp-R-HCT 116 cells (p53, ERK, and β-catenin) were suppressed by pKAL alone, but not others. However, some other Oxp-RR-Proteins of Oxp-R-HCT 116 cells that were not suppressed by pKAL alone were significantly suppressed by the combination treatment of pKAL and β-Lap. These findings suggest that pKAL enhanced the anti-cancer effects β-Lap by suppressing TERT, CD44, and EGFR-mediated multiple signaling networks as well as some of the Oxp-RR-Proteins of Oxp-R-HCT 116 cells. In conclusion, this study suggests that pKAL enhance the anticancer effects of β-Lap on OXP-R-Hct 116 cells by downregulating CD44, EGFR and some of the Oxp-RR-Proteins of Oxp-R-HCT 116 cells. Citation Format: Won Sup Lee, Eun Joo Jung, Hye Jung Kim, Sung Chul Shin, Gon Sup Kim, Jin-Myung Jung, Soon Chan Hong, Choong Won Kim. Artemisia annua Lpolyphenols augment b-lapachone effects on oxaliplatin-resistant HCT 116 colorectal cancer cells by downregulating TERT, CD44, EGFR and oxaliplatin resistance-related proteins of OXP-R-Hct 116 cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 1822.

β‐lapachone protects against doxorubicin‐induced hepatotoxicity through modulation of NAD+/SIRT‐1/FXR/p‐AMPK/NF‐kB and Nrf2 signaling axis

Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway

β-Lapachone Induces NAD(P)H:Quinone Oxidoreductase-1- and Oxidative Stress-Dependent Heat Shock Protein 90 Cleavage and Inhibits Tumor Growth and Angiogenesis

β-Lapachone, an NQO1 activator, alleviates diabetic cardiomyopathy by regulating antioxidant ability and mitochondrial function

Nicotinic Acid Riboside Regulates Nrf-2/P62-Related Oxidative Stress and Autophagy to Attenuate Doxorubicin-Induced Cardiomyocyte Injury

Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy

β-Lapachone induces ferroptosis of colorectal cancer cells via NCOA4-mediated ferritinophagy by activating JNK pathway

The protective effects of esculetin against Doxorubicin‐Induced hepatotoxicity in rats: Insights into the modulation of Caspase, FOXOs, and heat shock protein pathways

Efficacy of beta-lapachone in pancreatic cancer treatment: Exploiting the novel, therapeutic target NQO1

The protective effects of esculetin against Doxorubicin-Induced hepatotoxicity in rats: Insights into the modulation of Caspase, FOXOs, and heat shock protein pathways

Betaine ameliorates doxorubicin‐induced cardiomyopathy by inhibiting oxidative stress, inflammation, and fibrosis through the modulation of AMPK/Nrf2/TGF‐β expression

Abstract 1822: Artemisia annua L polyphenols augment b-lapachone effects on oxaliplatin-resistant HCT 116 colorectal cancer cells by downregulating TERT, CD44, EGFR and oxaliplatin resistance-related proteins of OXP-R-Hct 116 cells

Protective effects of esculetin against doxorubicin‐induced toxicity correlated with oxidative stress in rat liver: In vivo and in silico studies

Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1

Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats

Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy

Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes

Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway

Modulation of the Sirtuin-1 signaling pathway in doxorubicin-induced nephrotoxicity (synergistic amelioration by resveratrol and pirfenidone)

Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination

Synergistic Effect of β-Lapachone and Aminooxyacetic Acid on Central Metabolism in Breast Cancer